Devices and methods for detecting cells and other analytes

a cell and analyte technology, applied in the field of medical devices, medical diagnostics, cell counting, can solve the problems of guava easycd4 limited improvement, limited application prospects, and limited application prospects of laboratory monitoring tools to determine cd4 counts in resource-limited settings

Inactive Publication Date: 2014-12-16
THE GENERAL HOSPITAL CORP
View PDF12 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

This method provides a cost-effective, portable, and efficient means for CD4+ T cell counting with high purity and yield, suitable for resource-limited settings, capable of performing CD4 counts from a fingerprick sample in under 10 minutes, correlating well with flow cytometric results and addressing the challenges of sample preparation.

Problems solved by technology

However, affordable and appropriate laboratory monitoring tools to determine CD4 counts have little penetration in resource-limited settings, despite ongoing international efforts to extend the availability of ART to these areas.
Although these instruments are high throughput and accurate, their cost and technical requirements for operation and maintenance have limited their reach and significantly delayed the implementation of HIV treatment programs in resource-limited areas worldwide.
Smaller instruments like the Guava EasyCD4 offer limited improvements and have not been widely adopted.
However, they have much lower throughput, are more labor intensive and less accurate, and are not widely used or recommended by World Health Organization guidelines.
In addition, improvements on the back-end aspects of CD4 counting—such as miniaturization of equipment—do not address the most problematic issue for resource-limited settings, which is sample preparation.
The requirements to collect blood by venipuncture, to lyse erythrocytes, to centrifuge samples, or to use pipettes for any step in the diagnostic assay are extremely problematic in these settings.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Devices and methods for detecting cells and other analytes
  • Devices and methods for detecting cells and other analytes
  • Devices and methods for detecting cells and other analytes

Examples

Experimental program
Comparison scheme
Effect test

example 1

Isolation of CD4+ T Lymphocytes

[0081]Materials

[0082]3-Mercaptopropyl trimethoxysilane was purchased from Gelest (Morrisville, Pa.). Ethanol (200 proof), glass coverslips (35×60 mm, no. 1), hemacytometer and microslide fieldfinder were obtained from Fisher Scientific (Fair Lawn, N.J.). For chamber fabrication, SU-8 photoresist and developer were obtained from MicroChem (Newton, Mass.); silicone elastomer and curing agent were obtained from Dow Corning (Midland, Mich.). Phosphate buffered saline (PBS) was obtained from Mediatech (Herndon, Va.). Lyophilized bovine serum albumin (BSA) was obtained from Aldrich Chemical Co. (Milwaukee, Wis.). The coupling agent GMBS (N-γ-maleimidobutyryloxy succinimide ester) and NeutrAvidin were obtained from Pierce Biotechnology (Rockford, Ill.). Biotinylated mouse anti-human anti-CD4 (clone 13b8.2) was purchased from Beckman Coulter (Somerset, N.J.). Biotinylated mouse antihuman anti-CD36 (clone SMO) was obtained from Ancell (Bayport, Minn.). Alexa Fl...

example 2

Arrangements of Capture Chambers

[0099]A flat microfluidic chamber (FIG. 7) has been used for isolating various target cells from whole blood (Table 1). The principle for specific cell capture is the combination of specific antibodies, well controlled shear stress conditions inside the device, and efficient passivation of the surfaces to prevent nonspecific binding of unwanted cells. Following optimization, the purity of cell capture can be as high as 99% and the yield of capture as high as 80%. One approach for increasing the purity in unfavorable situations relies on the use of isolation chambers in series (FIG. 8), where the first chamber depletes the cells that would otherwise contaminate the sample of interest in the second chamber. The captured cells can be imaged using standard microscope (FIG. 9), counted, and RNA and protein extracted (FIG. 10) for further analysis.

example 3

HIV-Specific CD8 T Cell Isolation

[0100]We developed a PDMS microfluidic device coated with pMHC class I pentamers for the capture of disease-specific CD8+ T cells (FIG. 11). In our experiments, we used soft lithography and SU-8 fabrication techniques to create microchannels within a PDMS mold. The PDMS mold and a silica substrate were then exposed to oxygen plasma treatment before being irreversibly sealed together. The hydroxyl groups on the PDMS and silica surfaces were then treated with 3-mercaptotrimethoxysilane in anhydrous ethanol, resulting in the formation of thiol-terminal groups. After washing off unreacted silane solution with anhydrous ethanol, the PDMS device was flushed with the heterobifunctional crosslinker GMBS in anhydrous ethanol, during which the thiol group on the silane reacts specifically and covalently with the maleimide region of GMBS. This leaves the succinimide residue of the GMBS available for protein attachment, and after flushing unreacted GMBS with 1×P...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
shear stressaaaaaaaaaa
shear stressaaaaaaaaaa
shear stressaaaaaaaaaa
Login to View More

Abstract

The invention features methods, devices, and kits for the isolation of analytes (e.g., a cell). A sample containing a desired analyte is introduced into a microfluidic device containing moieties that bind the desired analyte. A shear stress is applied that is great enough to prevent binding of undesired analytes and low enough to allow binding of the analyte of interest. Once bound, the desired analytes can be analyzed (e.g., counted). The invention also features methods for determining a shear stress for isolating a desired analyte.

Description

CROSS-REFERENCE TO RELATED APPLICATIONS[0001]This application is a National Stage application under 35 U.S.C. §371 and claims benefit under 35 U.S.C. §119(a) of International Application No. PCT / US2007 / 006791, filed on Mar. 15, 2007, which, in turn, claims benefit of U.S. Provisional Application No. 60 / 782,470, filed Mar. 15, 2006, which is hereby incorporated by reference in its entirety.BACKGROUND OF THE INVENTION[0002]This invention relates to the fields of medical devices, medical diagnostics, and cell counting.[0003]Of the 40.4 million people infected with HIV globally, more than 35 million live in developing countries with significant resource limitations, many of whom are in urgent need of diagnosis, monitoring and antiretroviral therapy. In the process of managing HIV-infected subjects, counts of a specific white blood cell population, CD4+ T lymphocytes, have proven to be essential biological indicators. In adults, the absolute number of CD4+ T cells per microliter of blood...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & AuthorityPatents(United States)
IPC IPC(8): G01N33/53G01N33/569G01N33/543
CPCG01N33/56972Y10S436/824G01N33/56966
InventorIRIMIA, DANIELCHENG, XUANHONGTONER, MEHMETDEMIRCI, UTKANRODRIGUEZ, WILLIAM
OwnerTHE GENERAL HOSPITAL CORP